PNC Financial Services Group’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
PNC Financial Services Group's ANRO Position: Q3 2026 in Review
PNC Financial Services Group increased its Alto Neuroscience (ANRO) stake by 6.3% in Q3 2026, buying an estimated $2.28K and bringing the position to 1,276 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3619.
PNC Financial Services Group first reported a position in ANRO in Q1 2025 and has held it in 7 quarters since. 31 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- PNC Financial Services Group held 1,276 shares of Alto Neuroscience worth $32.6K as of Q3 2026.
- PNC Financial Services Group bought 76 Alto Neuroscience shares in Q3 2026, an estimated $2.28K.
- Alto Neuroscience made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3619 holding.
- PNC Financial Services Group first reported a position in Alto Neuroscience in Q1 2025 and has held it in 7 quarters since.
- 31 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.